This 👇… you do not want to miss this!!! Crystal Gadegbeku Georges Nakhoul Jonathan Taliercio, DO

Such a rewarding experience working on this paper alongside Shane Bobart, MD, FASN @HannySawaf

"IgA nephropathy may not be that slow progressive disease we once believed it was." This Editorial discusses the long-term effects of IgA nephropathy bit.ly/CJASN0171 Kenar Jhaveri Joyita Bharati HofNorthwell Kidney

Join ASN in celebrating #BlackHistoryMonth! This year, ASN is excited to feature its first Black President, Deidra C. Crews, MD, ScM, FASN, MACP. @DrDeidraCrews continues to advance kidney care daily by promoting health equity and advocating for more equitable care solutions.

Check out the Top 10 Takeaways for Clinicians from the KDIGO 2024 Lupus Nephritis Guideline: kdigo.co/Lupus-Nephriti… Visit the KDIGO Lupus Nephritis Guideline website to download the guideline and for more resources: kdigo.org/guidelines/lup… #lupus #nephritis #lupusnephritis

“The sodium was 113, they bolused two liters of saline down in the emergency room, repeat labs pending…”

Finally. We figured out the dense deposits in dense deposit disease (DDD). The answer is Apolipoprotein E. You can stain for APOE & make the diagnosis of DDD in >80% cases. Without electron 🔬. DDD was the reason I got into mass spectrometry 17 yrs ago. doi.org/10.1016/j.kint…

Final push here… 3 days to go!!!! #CCNephUpdate24. Join us and enjoy state of the art discussion and updates in the field…. Crystal Gadegbeku Jonathan Taliercio, DO Luke J. Laffin @CLindenmeyerMD Emily Littlejohn

Friday afternoon, right after lunch, and look at this packed auditorium to hear Carla Nester updating us on C3G… #CCNephUpdate24. What a treat!

A surreal moment during #CCNephUpdate24. Dr. Brad Rovin casually asking a question to Dr. Richard Glassock. Dr. Ali Mehdi moderating and Dr. Marc Pohl and Dr. Carol Langford all in one photo.

Tobias B. Huber presented research on anti-nephrin antibodies at #ERA24

the new anti PLA2r but this time for FSGS and MCD, promising results!!! #ERA24

KDIGO 2024 Update: 🚨Important Lupus Nephritis 🫘 Clinical Practical Guidelines- KDIGO #MedX #Medtwitter #nephrotwitter #rheumtwitter #medicine

Did you know there’s a risk score for predicting cisplatin nephrotoxicity? #kidneywk kidneycalc.org

Reminder: Registration is open for the 14th Annual Glomerular Disease 2025 Conference on Friday, February 7th, 2025. Feel free to register for our virtual conference using the following link: eventleaf.com/Attendee/Atten…

Check out #KDIGOGEMs 💎 a dynamic new program offering virtual education on the latest KDIGO Guidelines #Nephpearls Register here 👉 gems-gd.org/home

Membranous nephropathy treatment standard doi.org/10.1093/ndt/gf…

We are pleased to announce the publication of the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Read the news release: kdigo.co/2025-ADPKD-Gui… This first-ever KDIGO guideline focused

C3 glomerulopathy (C3G) is a rare form of glomerulonephritis, comprising two main subtypes. This year, we may see FDA approval of two new therapies specifically demonstrated to improve meaningful clinical outcomes in patients with C3G—something we have never had before.

Big day — our JAMA review on ADPKD is out today! 📢 Grateful to the JAMA editorial team for their partnership in shaping this into a high-impact resource for clinicians. If you manage patients with Polycystic Kidney Disease, we hope you’ll find it valuable.